<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9304532</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2286</journal-id>
<journal-id journal-id-type="nlm-ta">Stem Cells</journal-id>
<journal-id journal-id-type="iso-abbrev">Stem Cells</journal-id>
<journal-title-group>
<journal-title>Stem cells (Dayton, Ohio)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1066-5099</issn>
<issn pub-type="epub">1549-4918</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27422057</article-id>
<article-id pub-id-type="pmc">5195860</article-id>
<article-id pub-id-type="doi">10.1002/stem.2463</article-id>
<article-id pub-id-type="manuscript">NIHMS804027</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Establishment of reporter lines for detecting fragile X mental retardation (<italic>FMR1</italic>) gene reactivation in human neural cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Meng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Huashan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ananiev</surname>
<given-names>Gene E.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Musser</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ness</surname>
<given-names>Kathryn H.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maglaque</surname>
<given-names>Dianne L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saha</surname>
<given-names>Krishanu</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhattacharyya</surname>
<given-names>Anita</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Xinyu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Waisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA</aff>
<aff id="A2"><label>2</label>Small Molecule Screening Facility, University of Wisconsin-Madison, Madison, WI 53705, USA</aff>
<aff id="A3"><label>3</label>Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53705, USA</aff>
<aff id="A4"><label>4</label>Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, WI 53705, USA</aff>
<aff id="A5"><label>5</label>Department of Neuroscience, University of Wisconsin-Madison, Madison, WI 53705, USA</aff>
<author-notes>
<corresp id="CR1"><bold>Corresponding authors:</bold> Anita Bhattacharyya (Waisman Center, University of Wisconsin-Madison, WI 53705, USA; Phone 608-265-6142; <email>Bhattacharyy@Waisman.Wisc.Edu</email>), Xinyu Zhao (Waisman Center and Department of Neuroscience, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53705, USA; Phone: (608) 263-9906; <email>Xinyu.zhao@wisc.edu</email>)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>35</volume>
<issue>1</issue>
<fpage>158</fpage>
<lpage>169</lpage>
<!--elocation-id from pubmed: 10.1002/stem.2463-->
<abstract id="ABS1">
<p id="P1">Human patient-derived induced pluripotent stem cells (hiPSCs) provide unique opportunities for disease modeling and drug development. However, adapting hiPSCs or their differentiated progenies to high throughput assays for phenotyping or drug screening has been challenging. Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and a major genetic cause of autism. FXS is caused by mutational trinucleotide expansion in the <italic>FMR1</italic> gene leading to hypermethylation and gene silencing. One potential therapeutic strategy is to reactivate the silenced <italic>FMR1</italic> gene, which has been attempted using both candidate chemicals and cell-based screening. However, molecules that effectively reactivate the silenced <italic>FMR1</italic> gene are yet to be identified; therefore, a high throughput unbiased screen is needed. Here we demonstrate the creation of a robust <italic>FMR1</italic>-Nluc reporter hiPSC line by knocking in a Nano luciferase (Nluc) gene into the endogenous human <italic>FMR1</italic> gene using the CRISPR/Cas9 genome editing method. We confirmed that luciferase activities faithfully report <italic>FMR1</italic> gene expression levels and showed that neural progenitor cells derived from this line could be optimized for high throughput screening. The <italic>FMR1</italic>-Nluc reporter line is a good resource for drug screening as well as for testing potential genetic reactivation strategies. In addition, our data provide valuable information for the generation of knock-in human iPSC reporter lines for disease modeling, drug screening, and mechanistic studies.</p>
</abstract>
<abstract abstract-type="graphical" id="ABS2">
<title>Graphical abstract</title>
<p id="P2">We have created robust FMR1-luciferase reporter cell lines using genome editing. The reporter line faithfully reports endogenous FMR1 gene activation therefore will provide a critical resource for drug screening</p>
<p id="P3">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-804027-f0001.jpg"></graphic>
</p>
</abstract>
<kwd-group>
<kwd>Fragile X syndrome</kwd>
<kwd>FMR1</kwd>
<kwd>FMRP</kwd>
<kwd>drug discovery</kwd>
<kwd>induced pluripotent stem cells</kwd>
<kwd>luciferase</kwd>
<kwd>high throughput</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>